Abstract 7083: ABSK211, a highly potent and orally available pan-KRAS inhibitor, demonstrates robust antitumor efficacy in combination with multiple agents
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Qianqian Chen, Bin Shen, Xiao Chen, Jie Wang, Jie Zhang, Manqi Liu, Hongping Yu, Nannan Zhang
Institution: Abbisko Therapeutics Co., Ltd. (China)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148651217
Cites:
Cited by:
Related to: